Condition: Hepatocellular Carcinoma (HCC) · Sponsor: Seoul National University Hospital
In patients who has no sign suggesting high lung shunt fraction (TIPS, hepatic vein invasion, hepatic vein enhancement on arterial phase, dysmorphic intratumoral vessel), planning angiography, MAA scan, and radioembolization are performed in a single day with SIR-Spheres. This prospective registry will prove that the selection criteria is accurate and same-day radioembolization is feasible and safe.
This description comes directly from the study's public registry record.
Hyo-Cheol Kim, MD · 82-10-5136-5205 · radioembolization@snu.ac.kr
Always discuss trial participation with your own doctor first.
| National Cancer Center | Goyang, South Korea | Recruiting |
| Samsung Medical Center | Seoul, South Korea | Not Yet Recruiting |
| Seoul National University Hospital | Seoul, South Korea | Recruiting |
| Severance hospital | Seoul, South Korea | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06944483